GAMMA Investing LLC Has $784,000 Stock Position in Phibro Animal Health Corporation (NASDAQ:PAHC)

GAMMA Investing LLC lifted its position in Phibro Animal Health Corporation (NASDAQ:PAHC) by 2,011.4% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 36,718 shares of the company’s stock after acquiring an additional 34,979 shares during the period. GAMMA Investing LLC owned about 0.09% of Phibro Animal Health worth $784,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in PAHC. Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of Phibro Animal Health in the fourth quarter worth approximately $29,000. Lazard Asset Management LLC increased its position in shares of Phibro Animal Health by 2,739.7% in the fourth quarter. Lazard Asset Management LLC now owns 1,647 shares of the company’s stock worth $34,000 after acquiring an additional 1,589 shares in the last quarter. Aquatic Capital Management LLC acquired a new stake in shares of Phibro Animal Health during the fourth quarter worth approximately $69,000. Virtus Fund Advisers LLC acquired a new stake in shares of Phibro Animal Health during the fourth quarter worth approximately $69,000. Finally, Quantbot Technologies LP boosted its holdings in shares of Phibro Animal Health by 65.1% during the fourth quarter. Quantbot Technologies LP now owns 5,116 shares of the company’s stock worth $107,000 after purchasing an additional 2,018 shares during the period. 99.34% of the stock is owned by hedge funds and other institutional investors.

Phibro Animal Health Price Performance

NASDAQ PAHC opened at $24.45 on Wednesday. The company has a quick ratio of 1.23, a current ratio of 2.91 and a debt-to-equity ratio of 2.67. The stock has a market capitalization of $990.96 million, a PE ratio of 31.35, a price-to-earnings-growth ratio of 0.47 and a beta of 0.74. The company has a 50 day moving average price of $21.39 and a two-hundred day moving average price of $21.89. Phibro Animal Health Corporation has a 12-month low of $16.16 and a 12-month high of $26.55.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings data on Wednesday, May 7th. The company reported $0.63 earnings per share for the quarter, topping analysts’ consensus estimates of $0.52 by $0.11. Phibro Animal Health had a net margin of 2.68% and a return on equity of 30.51%. The business had revenue of $347.80 million during the quarter, compared to analysts’ expectations of $352.41 million. As a group, equities analysts predict that Phibro Animal Health Corporation will post 1.95 earnings per share for the current fiscal year.

Phibro Animal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Wednesday, June 4th will be paid a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.96%. The ex-dividend date is Wednesday, June 4th. Phibro Animal Health’s payout ratio is 61.54%.

Wall Street Analyst Weigh In

Several research firms recently commented on PAHC. BNP Paribas Exane upgraded shares of Phibro Animal Health from an “underperform” rating to a “neutral” rating and set a $24.00 price target for the company in a report on Monday. Morgan Stanley raised their price target on shares of Phibro Animal Health from $20.00 to $21.00 and gave the stock an “equal weight” rating in a report on Thursday, May 8th. Finally, Wall Street Zen upgraded shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a report on Friday, May 9th. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $20.80.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.